1. bookVolume 3 (2015): Issue 4 (December 2015)
    A special issue on chronic obstructive pulmonary disease (Guest Editor: Lawrence Grouse)
Journal Details
License
Format
Journal
eISSN
2224-4018
First Published
31 Dec 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Nutrition in chronic obstructive pulmonary disease: A review

Published Online: 30 Dec 2015
Volume & Issue: Volume 3 (2015) - Issue 4 (December 2015)<br/>A special issue on chronic obstructive pulmonary disease (Guest Editor: Lawrence Grouse)
Page range: 151 - 154
Journal Details
License
Format
Journal
eISSN
2224-4018
First Published
31 Dec 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Cachexia and muscle wasting is a frequent but partly reversible complication in patients with chronic obstructive pulmonary disease (COPD), and affects the disease progression and prognosis. Weight loss in COPD is a consequence of increased energy requirements unbalanced by dietary intake. Nutritional supplement therapy has been shown to be effective for maintaining and improving the muscle strength and exercise tolerance in poorly nourished COPD patients, thereby decreasing morbidity and mortality. This mini review discusses the role of nutritional supplement therapy in the treatment of COPD.

Keywords

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Revised 2015. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available at: www.goldcopd.org. Last accessed on November 2, 2015.Search in Google Scholar

2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28:523–32.10.1183/09031936.06.00124605Search in Google Scholar

3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765–73.10.1016/S0140-6736(07)61380-4Search in Google Scholar

4. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341–51.10.1016/S0140-6736(11)60968-9Search in Google Scholar

5. Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, et al. Prevalence of nutritional depletion in large out-patient population of patients with COPD. Respir Med 2006; 100: 1349–55.10.1016/j.rmed.2005.11.02316412624Search in Google Scholar

6. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008; 31: 492-501.10.1183/09031936.0007480718310396Search in Google Scholar

7. Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000; 6: 110–5.10.1097/00063198-200003000-0000510741769Search in Google Scholar

8. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79–83.10.1164/rccm.200506-969OC16368793Search in Google Scholar

9. Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82:53–9.10.1093/ajcn/82.1.53Search in Google Scholar

10. Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Am J Clin Nutr 2012; 95: 1385–95.10.3945/ajcn.111.02349922513295Search in Google Scholar

11. Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med 2006; 100: 561–7.10.1016/j.rmed.2005.05.02016019198Search in Google Scholar

12. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2013; 45: 2245–56.10.1016/j.biocel.2013.06.015Search in Google Scholar

13. Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol (1985) 2013; 114: 1253–62.10.1152/japplphysiol.00790.2012Search in Google Scholar

14. Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 54: 983–7.10.1093/ajcn/54.6.983Search in Google Scholar

15. Grönberg AM, Slinde F, Engström CP, Hulthén L, Larsson S. Dietary problems in patients with severe chronic obstructive disease. J Hum Nutr Diet 2005; 18: 445–52.10.1111/j.1365-277X.2005.00649.xSearch in Google Scholar

16. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59: 574–80.10.1136/thx.2003.019588Search in Google Scholar

17. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153: 633–7.10.1164/ajrccm.153.2.8564110Search in Google Scholar

18. Koehler F, Doehner W, Hoernig S, Witt C, Anker SD, John M. Anorexia in chronic obstructive pulmonary disease-association to cachexia and hormonal derangement. Int J Cardiol 2007; 119: 83–9.10.1016/j.ijcard.2006.07.088Search in Google Scholar

19. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85–97.10.1038/nri2921Search in Google Scholar

20. Breyer MK, Rutten EP, Locantore NW, Watkins ML, Miller BE, Wouters EF. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease. Nat Rev Immunol 2011; 11: 85–97.Search in Google Scholar

21. Görek Dilektaşli A, Ulubay G, Bayraktar N, Eminsoy I, Oner Eyüboğlu F. The effects of cachexia and related components on pulmonary functions in patients with COPD. Tuberk Toraks 2009; 57: 298-305.Search in Google Scholar

22. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362: 217-27.10.1056/NEJMoa0808836Search in Google Scholar

23. Donahoe M. Nutritional support in advanced lung disease. The pulmonary cachexia syndrome. Clin Chest Med 1997; 18: 547-61.10.1016/S0272-5231(05)70401-9Search in Google Scholar

24. Balkom van RH, Heijden van der HF, Herwaarden van CL, Dekhuijzen PN. Corticosteroid induced myopathy of the respiratory muscles. Neth J Med 1994; 45: 114–22.Search in Google Scholar

25. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033–47.10.1093/ajcn/71.5.1033Search in Google Scholar

26. Schols AM, Wouters EF. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21: 753-62.10.1016/S0272-5231(05)70182-9Search in Google Scholar

27. Berthon BS, Wood LG. Nutrition and Respiratory Health—Feature Review. Nutrients 2015; 7: 1618–43.10.3390/nu7031618Search in Google Scholar

28. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 12:CD000998.10.1002/14651858.CD000998.pub3Search in Google Scholar

29. Cai B, Zhu Y, Ma Yi, Xu Z, Zao Yi, Wang J, et al. Comer G.M. Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients. Nutrition 2003; 19: 229–32.10.1016/S0899-9007(02)01064-XSearch in Google Scholar

30. Shaheen SO, Jameson KA, Syddall HE, Aihie Sayer A, Dennison EM, Cooper C, et al. The relationship of dietary patterns with adult lung function and COPD. Eur Respir J 2010; 36: 277–84.10.1183/09031936.0011470920075056Search in Google Scholar

31. Rawal G, Yadav S, Shokeen P, Nagayach S. Medical nutrition therapy for the critically ill. Int J Health Sci Res 2015; 5: 384-93.Search in Google Scholar

32. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001; 36:1183–93.10.1007/s11745-001-0831-411795850Search in Google Scholar

33. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 2012; 7: e38934.10.1371/journal.pone.0038934338086322737223Search in Google Scholar

34. Sundar IK, Hwang JW, Wu S, Sun J, Rahman I. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun 2011; 406: 127–33.10.1016/j.bbrc.2011.02.011304984121300024Search in Google Scholar

35. Rawal G, Yadav S, Shokeen P. Health and the vitamin D. Int J Health Sci Res 2015; 5: 416-23.Search in Google Scholar

36. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44: 1504–20.10.1183/09031936.0007091425234804Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo